Sanofi said its amlitelimab drug confirmed its potential to treat eczema in patients 12 years and older in two late-phase ...
We recently published 10 Stocks Delivering Double-Digit Gains Effortlessly; 4 Hit Highs. Corvus Pharmaceuticals Inc.
Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, ...
Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...
Investor's Business Daily on MSN
Why small biotech stock Corvus Pharma just launched to a nine-year high
Biotech stock Corvus Pharmaceuticals catapulted to a nine-year high Tuesday on promising results in eczema treatment.
FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly announced on Friday ...
A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...
LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm Hawaii 2026 (Jan. 25-29), showcasing a comprehensive body of evidence across ...
The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate to severe atopic dermatitis (AD) in children 12-17 years old, ...
Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of eczema, known as atopic dermatitis, is characterized by persistent itching ...
The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results